Literature DB >> 1829096

Immunoregulation in onchocerciasis. Functional and phenotypic abnormalities of lymphocyte subsets and changes with therapy.

D O Freedman1, A Lujan-Trangay, C Steel, C Gonzalez-Peralta, T B Nutman.   

Abstract

To help define the immunoregulatory defects in patients with onchocerciasis, flow cytometric analysis of circulating lymphocyte subpopulations was performed in parallel with functional assays. No significant differences in CD4/CD8 ratios were seen when microfilariae-positive individuals from Guatemala were compared with Guatemalan controls. However, the infected individuals had significantly increased numbers of circulating CD4+CD45RA+ lymphocytes (mean 38.3%) when compared with controls (mean 16.0%). Coexpression of the activation marker HLA-DR was significantly increased on CD4+ cells from infected individuals. In contrast, no up-regulation of HLA-DR was seen on CD8+ or CD19+ cells. At 1 year after initiation of treatment with semiannual doses of the microfilaricide ivermectin, there were significant increases (P less than 0.05) in the percentage of CD4+CD45RA- cells, the percentage of CD4+HLA-DR+ cells, and mitogen-induced lymphokine production (IL-2, IL-4). Despite these changes, parasite-specific IL-2 and IL-4 production which had been undetectable before treatment did not manifest itself even by the 2-yr follow-up. Defects in the T-cell activation pathway in Onchocerca volvulus-infected individuals may thus exist at several independent points; a state of parasite antigen-specific tolerance appears to remain even after the relative reversal of other generalized immunoregulatory defects.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1829096      PMCID: PMC296024          DOI: 10.1172/JCI115282

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Reduction in the number of UCHL-1+ cells and IL-2 production in the peripheral blood of patients with visceral leishmaniasis.

Authors:  E Cillari; S Milano; M Dieli; E Maltese; S Di Rosa; S Mansueto; A Salerno; F Y Liew
Journal:  J Immunol       Date:  1991-02-01       Impact factor: 5.422

2.  Abnormalities in CD4+ T-lymphocyte subsets in inflammatory rheumatic diseases.

Authors:  C Morimoto; P L Romain; D A Fox; P Anderson; M DiMaggio; H Levine; S F Schlossman
Journal:  Am J Med       Date:  1988-05       Impact factor: 4.965

3.  Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells.

Authors:  A N Akbar; L Terry; A Timms; P C Beverley; G Janossy
Journal:  J Immunol       Date:  1988-04-01       Impact factor: 5.422

4.  Human naive and memory T cells: reinterpretation of helper-inducer and suppressor-inducer subsets.

Authors:  M E Sanders; M W Makgoba; S Shaw
Journal:  Immunol Today       Date:  1988 Jul-Aug

5.  Fixation and long-term storage of human lymphocytes for surface marker analysis by flow cytometry.

Authors:  R B Lal; L J Edison; T M Chused
Journal:  Cytometry       Date:  1988-05

6.  Induction of non-specific human suppressor cells in vitro by defined Onchocerca volvulus antigens.

Authors:  M A Ouaissi; J P Dessaint; J Cornette; I Desmoutis; A Capron
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

7.  The isolation and characterization of the human suppressor inducer T cell subset.

Authors:  C Morimoto; N L Letvin; J A Distaso; W R Aldrich; S F Schlossman
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

8.  Deficiency of the suppressor inducer subset of T lymphocytes in rheumatoid arthritis.

Authors:  P Emery; K C Gentry; I R Mackay; K D Muirden; M Rowley
Journal:  Arthritis Rheum       Date:  1987-08

9.  Onchocerciasis and immunity in humans: enhanced T cell responsiveness to parasite antigen in putatively immune individuals.

Authors:  D J Ward; T B Nutman; G Zea-Flores; C Portocarrero; A Lujan; E A Ottesen
Journal:  J Infect Dis       Date:  1988-03       Impact factor: 5.226

10.  Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody.

Authors:  C Morimoto; D A Hafler; H L Weiner; N L Letvin; M Hagan; J Daley; S F Schlossman
Journal:  N Engl J Med       Date:  1987-01-08       Impact factor: 91.245

View more
  9 in total

1.  Down-regulated lymphoproliferation coincides with parasite maturation and with the collapse of both gamma interferon and interleukin-4 responses in a bovine model of onchocerciasis.

Authors:  S P Graham; A J Trees; R A Collins; D M Moore; F M Guy; M J Taylor; A E Bianco
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

2.  Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals.

Authors:  M Clerici; F T Hakim; D J Venzon; S Blatt; C W Hendrix; T A Wynn; G M Shearer
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

3.  Chronic immune activation associated with intestinal helminth infections results in impaired signal transduction and anergy.

Authors:  G Borkow; Q Leng; Z Weisman; M Stein; N Galai; A Kalinkovich; Z Bentwich
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

4.  Decreased CD4 and increased CD8 counts with T cell activation is associated with chronic helminth infection.

Authors:  A Kalinkovich; Z Weisman; Z Greenberg; J Nahmias; S Eitan; M Stein; Z Bentwich
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

5.  Interleukin-5 is the predominant cytokine produced by peripheral blood mononuclear cells in alveolar echinococcosis.

Authors:  D Sturm; J Menzel; B Gottstein; P Kern
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

6.  Evidence for an abnormal profile of interleukin-4 (IL-4), IL-5, and gamma-interferon (gamma-IFN) in peripheral blood T cells from patients with allergic eosinophilic gastroenteritis.

Authors:  J S Jaffe; S P James; G E Mullins; L Braun-Elwert; I Lubensky; D D Metcalfe
Journal:  J Clin Immunol       Date:  1994-09       Impact factor: 8.317

7.  Ivermectin-facilitated immunity in onchocerciasis. Reversal of lymphocytopenia, cellular anergy and deficient cytokine production after single treatment.

Authors:  P T Soboslay; C M Dreweck; W H Hoffmann; C G Lüder; C Heuschkel; H Görgen; M Banla; H Schulz-Key
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

8.  Epitopes of the Onchocerca volvulus RAL1 antigen, a member of the calreticulin family of proteins, recognized by sera from patients with onchocerciasis.

Authors:  L A Rokeach; P A Zimmerman; T R Unnasch
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

9.  Wuchereria bancrofti infection is linked to systemic activation of CD4 and CD8 T cells.

Authors:  Inge Kroidl; Mkunde Chachage; Jonathan Mnkai; Anthony Nsojo; Myrna Berninghoff; Jaco J Verweij; Lucas Maganga; Nyanda E Ntinginya; Leonard Maboko; Petra Clowes; Michael Hoelscher; Elmar Saathoff; Christof Geldmacher
Journal:  PLoS Negl Trop Dis       Date:  2019-08-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.